All stock lists
Unlock the score InsiderBuyingOur analysisTwo Retension Pharmaceuticals Insiders Buy $369,600 of StockFranklin M Berger and Eric L. Keller are both recorded as buyers at Retension Pharmaceuticals, with purchases dated October 13th, 2026 totaling $369,600. The shares last traded at $15.Oct 22, 2026InsiderBuyingOur analysisTwo Retension Pharmaceuticals Insiders Buy $369,600 of StockFranklin M Berger and Eric L. Keller are the two insiders on the buy side at Retension Pharmaceuticals, with $369,600 in purchases recorded on October 13th, 2026. Shares were last marked at $11.63.Oct 14, 2026
Retension Pharmaceuticals, Inc. (NASDAQ:RTSN)
US · Delayed Price · Currency is USD
Healthcare · Medical - Pharmaceuticals
14.84
Insider Score
/ 100
RTSN Insider Score
Retension Pharmaceuticals, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
Company News & Press Releases
No press releases on file for RTSN.
Our Coverage
InsiderBuyingOur analysisTwo Retension Pharmaceuticals Insiders Buy $369,600 of StockFranklin M Berger and Eric L. Keller are both recorded as buyers at Retension Pharmaceuticals, with purchases dated October 13th, 2026 totaling $369,600. The shares last traded at $15.Oct 22, 2026InsiderBuyingOur analysisTwo Retension Pharmaceuticals Insiders Buy $369,600 of StockFranklin M Berger and Eric L. Keller are the two insiders on the buy side at Retension Pharmaceuticals, with $369,600 in purchases recorded on October 13th, 2026. Shares were last marked at $11.63.Oct 14, 2026Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.